Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |